Daniel Ramos
About Daniel Ramos
Daniel Ramos is a postdoctoral researcher currently at the National Institutes of Health, specializing in Alzheimer's disease modeling using human induced pluripotent stem cells. He has a strong academic background with a PhD in Neuroscience from The Johns Hopkins University School of Medicine and has held various research positions at prestigious institutions.
Work at National Institutes of Health
Daniel Ramos has been employed as a Postdoctoral Researcher at the National Institutes of Health since 2020. In this role, he focuses on advanced modeling of Alzheimer's disease, utilizing human induced pluripotent stem cells (iPSCs). His work contributes to the understanding of neurodegenerative diseases through innovative research methodologies.
Previous Experience at Johns Hopkins University
Daniel Ramos worked at The Johns Hopkins University School of Medicine in various capacities. He served as an NRSA Graduate Research Fellow in the Department of Neuroscience PhD Program from 2013 to 2020. Additionally, he held a position as a Postdoctoral Fellow for five months in 2019 to 2020. His extensive experience at this institution has significantly shaped his research trajectory.
Research Experience at University of Pennsylvania
At the University of Pennsylvania, Daniel Ramos held multiple research roles. He was an Undergraduate Researcher from 2009 to 2013 and later served as an Instructor and mentor for the Upward Bound Math and Science program in 2013. His involvement in these roles provided him with foundational research skills and mentoring experience.
Education and Expertise
Daniel Ramos earned a Bachelor of Arts in Neuroscience from the University of Pennsylvania, completing his studies from 2009 to 2013. He then pursued a Doctor of Philosophy (PhD) in Neuroscience at The Johns Hopkins University School of Medicine, where he studied from 2013 to 2019. His educational background equips him with a strong foundation in neuroscience and advanced research techniques.
Research Specialization
Daniel Ramos specializes in the application of CRISPR interference (CRISPRi) technology to investigate genetic mutations associated with Alzheimer's disease. His research also emphasizes the use of transcriptomics and proteomics in stem cell research, aiming to deepen the understanding of neurodegenerative diseases and their underlying mechanisms.